Desunyunxing Showcases AI-Powered Ultrasound Solutions at CMEF to Advance Tiered Healthcare Delivery

From May 13 to 16, the 84th China International Medical Equipment Fair (Spring) (CMEF), themed “Innovative Technology, Leading the Future with Intelligence,” opened at the National Exhibition and Convention Center (Shanghai). As a leader in the field of “AI + Medical Imaging,” Deshang Yunxing attended the expo with its portfolio of AI-powered ultrasound products. The company showcased multiple cutting-edge AI-driven innovations, fully demonstrating its frontier technological capabilities in artificial intelligence and its strength in providing comprehensive services to customers in the medical imaging market, drawing significant attention.

Founded in 1979, the China International Medical Equipment Fair (CMEF) is held twice a year, in spring and autumn. After more than 40 years of innovative development, it has become a globally leading healthcare technology platform covering the entire industry chain, integrating functions such as technological innovation and new product launches. CMEF showcases tens of thousands of products, technologies, and solutions, including medical imaging, smart healthcare, and medical software. The exhibition annually attracts over 7,000 brand manufacturers from more than 30 countries and regions worldwide to participate.

During the conference, Deshang Yunxing’s custom-built booth (No. 3A09) in the Medical Imaging Pavilion showcased its product portfolio, including the AI-SCAN™ Automated Ultrasound Scanning Robot, the PIONEER 3D Targeted Minimally Invasive Surgical Robot, and its AI-powered ultrasound series. The display attracted numerous clinical experts, scholars, and industry professionals, who stopped to observe and praised the innovations.

The ultrasound AI diagnostic system showcased by Deshang Yunxing integrates artificial intelligence with clinical practice, based on its independently developed deep learning technology platform, DE-Light AI.

It is understood that the Intelligent AI-Assisted Diagnostic System for Thyroid Nodules via Ultrasound is a “star product” in this field. Its principle involves leveraging artificial intelligence algorithms to recognize and annotate ultrasound imaging features of thyroid nodules, thereby assisting physicians in making more accurate diagnostic conclusions. In terms of outcomes, while the accuracy of ultrasound-based judgments by physicians at tertiary Grade A hospitals originally ranged from 60% to 70%, with the assistance of this system, even primary-care physicians can achieve an accuracy rate exceeding 90%.

The value of Deshang Yunxing’s AI products lies in enabling young physicians to rapidly enhance their diagnostic proficiency and efficiency through the assistance of this series of ultrasound AI solutions. For patients, it helps reduce missed and misdiagnoses. At the national level, it can significantly lower healthcare insurance expenditures, thereby benefiting society as a whole.

By participating in this exhibition, Deshang Yunxing showcased its latest technologies, achievements, and products to users, making substantial contributions to China’s tiered diagnosis and treatment system. Meanwhile, leveraging the extensive platform provided by the exhibition, the company further enhanced and optimized its technologies and products to address critical bottlenecks in healthcare-related fields and better meet the needs of a broad user base.

Desun Yunxing Medical Technology, established in 2013, is dedicated to the research and development and application of cutting-edge medical products, including medical big data and artificial intelligence, machine vision, 3D precision surgical planning and postoperative assessment, surgical navigation robots, automated ultrasound scanning robots, and solutions for medical consortia and medical communities. Particularly in the field of AI-based ultrasound diagnosis, Desun Yunxing is one of the earliest companies in China to engage in R&D. It has developed the AI-SONIC series of products for the thyroid, breast, pelvic floor, liver, and carotid artery, and will continue to deepen its presence in the AI ultrasound market to maintain a comprehensive industry-leading position. Desun Yunxing is the sole author of the Ultrasound AI chapter of the "White Paper on Artificial Intelligence in Chinese Medical Imaging."

Deshang Yunxing’s R&D team, anchored by renowned experts and scholars from China and abroad, has conducted academic research at prestigious international institutions including Harvard University, the Courant Institute of Mathematical Sciences at New York University, the Einstein Institute in Germany, the University of Tokyo, and The Chinese University of Hong Kong. The team has published nearly 100 academic papers in authoritative international journals. Building upon the most advanced foundational algorithm theories and the latest research achievements in image processing both domestically and internationally, the R&D team has independently developed numerous high-performance, rapid algorithms and highly innovative mathematical models, establishing distinctive algorithmic capabilities. In March 2019, the Algorithm Department of Deshang Yunxing was awarded the Second Prize of the National Science and Technology Progress Award by the Ministry of Education.